Haematology 12 - Lymphoma 2 Flashcards

(33 cards)

1
Q

How do Reed Sternberg cells appear on the blood film?

A

Giant cell surrounded by reactive eosinophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the age distribution of Hodgkin’s lymphoma?

A

Females 20-29 (typically nodular sclerosing)

M=F, elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the symptoms of Hodgkin’s lymphoma?

A

Painless lymphadenopathy, that becomes painful on drinking alcohol
Constitutional B symptoms
If advanced lymphadenopathy, may –> obstructive symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the cause of constitutional B symptoms in lymphoma?

A

Hyper-catabolic state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which investigation is used to diagnose hodgkin’s lymphoma, and which diagnosis is used for staging?

A

Diagnosis: LN biopsy
Staging: FDG-PET

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Recall the different stages of Hodgkin’s lymphoma

A

I: one group of nodes
II: >1 group of nodes, on one side of the diaphragm
III: Nodes on both sides of the diaphragm
IV: extranodal spread
Then:
A: no B symptoms
B: one/ any of fever/ weight loss/ night sweats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which subtype of lymphoma is most likely to affect young women?

A

Nodular sclerosing Hodgkin’s

Nodular lymphocyte predominant Hodgkin’s mainly affects the elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What type of chemotherapy is used in Hodgkin’s lymphoma?

A

ABVD
All patients started on chemo even if stage1
This drug regimen preserves fertility

Patients considered for rituximab (anti-cd20) or nivolumab (PD1 inhibitor- increases anti-tumour activity of T cells) if they fail ABVD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

After how many cycles of chemotherapy for Hodgkin’s lymphoma should the FDG-PET be repeated to check response?

A

After 2 cycles

And at the end of the treatment (outcomes of this will recommend if radiotherapy is needed or not)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the risk of giving radiotherapy for Hodgkin’s lymphoma?

A

It produces a lot of collateral damage, and when given alongside chemotherapy increases the risk of secondary malignany significantly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Recall 4 prognostic markers in lymphoma

A
  1. LDH
  2. Performance status
  3. HIV serology- increases risk of b-cell lymphomas due to underactive t-cells
  4. Hep B serology-immunotherapy regimens can lead to reactivation of virus and subsequent liver damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How aggressive is diffuse large B cell non-Hodgkin’s lymphoma?

A

High grade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How aggressive is follicular non-Hodgkin’s lymphoma?

A

Indolent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is diffuse large B cell non-Hodgkin’s lymphoma treated?

A

R-CHOP
Patients who relapse are considered for autologous stem cell transplantation (25% cure rate)

Aim of treatment is to cure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What mutation is commonly associated with follicular non-Hodgkin’s lymphoma?

A

t(14;18)

Translocation of Bcl2 –> oncogene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which subtype of non-Hodgkin’s lymphoma is associated with chronic H. pylori?

A

Extra-nodal marginal zone lymphoma

17
Q

What are the symptoms of extra-nodal marginal zone lymphoma?

A

Epigastric pain, ulceration and bleeding

18
Q

How aggressive is enteropathy-associated non-hodgkin’s lymphoma?

A

Very aggressive

19
Q

What is the main association of enteropathy-associated non-hodgkin’s lymphoma?

20
Q

What finding on a blood film is typial of CLL?

A

Smear/ smudge cells

21
Q

Recall the surface markers of intermediate B cells vs mature B cells vs CLL mature B cells

A

Intermediate B cell: CD5 positive
Mature B cell: CD19 positive
Mature CLL B cell: CD5 positive and CD19 positive

22
Q

What are the 2 staging methods that can be used in CLL?

A

Rai staging

Binet staging

23
Q

Is CLL a pre- or post-germinal centre malignancy?

A

50% pre, 50% post

24
Q

How can pre- and post-germinal centre CLL be differentiated?

A

VDJ sequencing

Pre germinal centre-Unmutated VDJ= much worse prognosis

25
Which mutation is associated with a particularly poor prognosis in CLL?
17p deletion (TP53)
26
What is Richter's syndrome?
Rare transformation of CLL to high grade lymphoma
27
Recall 3 classes of targeted therapy that can be given to treat CLL
1. BCR kinase inhibitors (eg ibrutinib and idelalisib)- BCR Kinase important in B Cell signalling, blocking this results in B cell depletion 2. BCL2 inhibitors (eg venetoclax)- promotes apoptosis 3. CAR-T and other experimental cell-based therapies
28
What type of lymph node biopsy will help you diagnose lymphomas
Excision biopsy or core biopsy Fine needle aspirate is useless- while not tell you anything because wont show you the structure of the lymph node. All the cells will just be smeared on the slide
29
Which of the Classical Hodgkin's has a poor prognosis?
Lymphocyte depleted cHL
30
How to differentiate symptoms of HL and NHL
HL will have more contiguous spread with patients often presenting with mediastinal masses. NHL will be more widespread Both will present with painless lymphadenopathy, B symptoms (except MZL) and compression symptoms, but in HL there might be painful lymph nodes after drinking
31
How is follicular non-Hodgkin's lymphoma treated?
R-COP Treatment is not curative Watch and wait recommended first, only treat if clinically indicated (compression symptoms, painful nodes, recurrent infections)
32
Laboratory findings of CLL
Lymphocytosis (5-300 x 10^9) Smear cells Normocytic normochromic anaemia Thrombocytopaenia Cancer of mature b lymphocytes (pre and post germinal follicle)
33
Poor prognostic markers of CLL
CD38 pre-GC, IgH unmutated 17p(TP53) deletion